While all UN sanctions are âtargetedâ in the sense that they are directed at a specific country or group, sanctions on individuals seeks to prevent harming the general population. This new tool presents new challenges, however, as names of individuals may be unfairly or hastily placed on Council lists.
MONDAY, March 19 (HealthDay News) -- A new type of medication for type 2 diabetes helps to lower blood sugar levels when used in concert with insulin and other diabetes drugs, new research suggests.
Glucagon-like peptide-1 (GLP-1) agonists increase insulin levels when needed, reduce the amount of glucose produced by the liver and reduce the rate of digestion. As a result, people may have less appetite and lose weight. Intermountain Healthcare answered. A GLP-1 agonist is a type of medication used to treat type 2 diabetes. It is taken by injection (shot) using a prefilled dosing pen. A GLP-1 agonist works with other diabetes medications -- pills, not insulin -- to help control your blood glucose.